Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning

Nature Medicine

Volumn 9, Issue 4, 2003, Pages 416-423

  Ye, Qing Hai ^a   Qin, Lun Xiu ^a   Forgues, Marshonna ^b   He, Ping ^b   Kim, Jin Woo ^b   Peng, Amy C ^b,c   Simon, Richard ^b   Li, Yan ^a   Robles, Ana I ^b   Chen, Yidong ^d   Ma, Zeng Chen ^a   Wu, Zhi Quan ^a   Ye, Sheng Long ^a   Liu, Yin Kun ^a   Tang, Zhao You ^a   Wang, Xin Wei ^b  

^a FUDAN UNIVERSITY   (China)

^b NATIONAL CANCER INSTITUTE   (United States)

^c EMMES CORPORATION   (United States)

^d NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; OSTEOPONTIN;

ADULT; ALGORITHM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INVASION; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; DRUG TARGETING; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENETIC ANALYSIS; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; LIVER METASTASIS; LUNG METASTASIS; MALE; MOUSE; NONHUMAN; ONCOGENE; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; TUMOR;

ALGORITHMS; ANIMALS; ARTIFICIAL INTELLIGENCE; CARCINOMA, HEPATOCELLULAR; FEMALE; GENE EXPRESSION PROFILING; HEPATITIS B VIRUS; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MICE; MICE, NUDE; MIDDLE AGED; NEOPLASM METASTASIS; OSTEOPONTIN; SIALOGLYCOPROTEINS;

ANIMALIA; HEPATITIS B VIRUS; MUS MUSCULUS;

EID: 0037391756     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm843     Document Type: Article

References (45)

1. Parkin, D.M., Pisani, P. & Ferlay, J. Global cancer statistics. CA Cancer J. Clin. 49, 33-64 (1999).
2. Pisani, P., Parkin, D.M., Bray, F. & Ferlay, J. Estimates of the worldwide mortality from 25 cancers in 1990. Int. J. Cancer 83, 18-29 (1999).
3. El-Serag, H.B. & Mason, A.C. Rising incidence of hepatocellular carcinoma in the United States. N. Engl. J. Med. 340, 745-750 (1999).
4. Taylor-Robinson, S.D., Foster, G.R., Arora, S., Hargreaves, S. & Thomas, H.C. Increase in primary liver cancer in the UK, 1979-94. Lancet 350, 1142-1143 (1997).
5. Curley, S.A. et al. Identification and screening of 416 patients with chronic hepatitis at high risk to develop hepatocellular cancer. Ann. Surg. 222, 375-380 (1995).
6. Larcos, G., Sorokopud, H., Berry, G. & Farrell, G.C. Sonographic screening for hepatocellular carcinoma in patients with chronic hepatitis or cirrhosis: an evaluation. AJR Am. J. Roentgenol. 171, 433-435 (1998).
7. Yang, B. et al. Prospective study of early detection for primary liver cancer. J. Cancer Res. Clin. Oncol. 123, 357-360 (1997).
8. Izzo, F. et al. Outcome of 67 patients with hepatocellular cancer detected during screening of 1125 patients with chronic hepatitis. Ann. Surg. 227, 513-518 (1998).
9. Bolondi, L. et al. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. Gut 48, 251-259 (2001).
10. Tang, Z.Y. Hepatocellular carcinoma-cause, treatment and metastasis. World J. Gastroenterol. 7, 445-454 (2001).
11. Zhou, X.D. et al. Experience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma. Cancer 91, 1479-1486 (2001).
12. Yuki, K., Hirohashi, S., Sakamoto, M., Kanai, T. & Shimosato, Y. Growth and spread of hepatocellular carcinoma. A review of 240 consecutive autopsy cases. Cancer 66, 2174-2179 (1990).
13. Genda, T. et al. Cell motility mediated by rho and rho-associated protein kinase plays a critical role in intrahepatic metastasis of human hepatocellular carcinoma. Hepatology 30, 1027-1036 (1999).
14. Mitsunobu, M., Toyosaka, A., Oriyama, T., Okamoto, E. & Nakao, N. Intrahepatic metastases in hepatocellular carcinoma: the role of the portal vein as an efferent vessel. Clin. Exp. Metastasis 14, 520-529 (1996).
15. Lindsay, C.K., Sinha, C.C. & Thorgeirsson, U.P. Morphological study of vascular dissemination in a metastatic hepatocellular carcinoma model in the monkey. Hepatology 26, 1209-1215 (1997).
16. Kuriyama, S. et al. Analysis of intrahepatic invasion of hepatocellular carcinoma using fluorescent dye-labeled cells in mice. Anticancer Res. 18, 4181-4188 (1998).
17. Osada, T. et al. E-cadherin is involved in the intrahepatic metastasis of hepatocellular carcinoma. Hepatology 24, 1460-1467 (1996).
18. Guo, X.Z. et al. KA1, a new metastasis suppressor gene, is reduced in metastatic hepatocellular carcinoma. Hepatology 28, 1481-1488 (1998).
19. Hui, A.M., Li, X., Makuuchi, M., Takayama, T. & Kubota, K. Over-expression and lack of retinoblastoma protein are associated with tumor progression and metastasis in hepatocellular carcinoma. Int. J. Cancer 84, 604-608 (1999).
20. Schena, M., Shalon, D., Davis, R.W. & Brown, P.O. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270, 467-470 (1995).
21. Bittner, M. et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 406, 536-540 (2000).
22. Alizadeh, A.A. et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403, 503-511 (2000).
23. Perou, C.M. et al. Molecular portraits of human breast tumours. Nature 406, 747-752 (2000).
24. Pomeroy, S.L. et al. Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 415, 436-442 (2002).
25. Shipp, M.A. et al. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat. Med. 8, 68-74 (2002).
26. Khan, I. et al. Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat. Med. 7, 673-679 (2001).
27. Okabe, H. et al. Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression. Cancer Res. 61, 2129-2137 (2001).
28. Xu, X.R. et al. Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver. Proc. Natl. Acad. Sci. USA 98, 15089-15094 (2001).
29. Radmacher, M.D., McShane, L.M. & Simon, R. A paradigm for class prediction using gene expression profiles. J. Comput. Biol. 9, 505-511 (2002).
30. Singhal, H. et al. Elevated plasma osteopontin in metastatic breast cancer associated with increased tumor burden and decreased survival. Clin. Cancer Res. 3, 605-611 (1997).
31. Fedarko, N.S., Jain, A., Karadag, A., Van Eman, M.R. & Fisher, L.W. Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer. Clin. Cancer Res. 7, 4060-4066 (2001).
32. Li, Y. et al. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray. J. Cancer Res. Clin. Oncol. (doi 10.1007/s00432-002-0396-4).
33. Qin, L.X. et al. The association of chromosome 8p deletion and tumor metastasis in human hepatocellular carcinoma. Cancer Res. 59, 5662-5665 (1999).
34. Hanahan, D. & Weinberg, R.A. The hallmarks of cancer. Cell 100, 57-70 (2000).
35. Sharp, J.A., Sung, V., Slavin, J., Thompson, E.W. & Henderson, M.A. Tumor cells are the source of osteopontin and bone sialoprotein expression in human breast cancer. Lab. Invest. 79, 869-877 (1999).
36. Urquidi, V. et al. Contrasting expression of thrombospondin-1 and osteopontin correlates with absence or presence of metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis. Clin. Cancer Res. 8, 61-74 (2002).
37. Chen, H., Ke, Y., Oates, A.J., Barraclough, R. & Rudland, P.S. Isolation of and effector for metastasis-inducing DNAs from a human metastatic carcinoma cell line. Oncogene 14, 1581-1588 (1997).
38. Oates, A.J., Barraclough, R. & Rudland, P.S. The identification of osteopontin as a metastasis-related gene product in a rodent mammary tumour model. Oncogene 13, 97-104 (1996).
39. Denhardt, D.T., Giachelli, C.M. & Rittling, S.R. Role of osteopontin in cellular signaling and toxicant injury. Annu. Rev. Pharmacol. Toxicol. 41, 723-749 (2001).
40. Weber, G.F. The metastasis gene osteopontin: a candidate target for cancer therapy. Biochim. Biophys. Acta 1552, 61-85 (2001).
41. Medico, E. et al. Osteopontin is an autocrine mediator of hepatocyte growth factor-induced invasive growth. Cancer Res. 61, 5861-5868 (2001).
42. Edmondson, H.A. & Steiner, P.E. Primary carcinoma of the liver. A study of 100 cases among 48900 necropsies. Cancer 7, 462-503 (1954).
43. Wu, C.G. et al. Distinctive gene expression profiles associated with hepatitis B virus x protein. Oncogene 20, 3674-3682 (2001).
44. Eisen, M.B., Spellman, P.T., Brown, P.O. & Botstein, D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA 95, 14863-14868 (1998).
45. Brazma, A. et al. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat. Genet. 29, 365-371 (2001).